keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
P8RI (D-P8RI) is a CD31 biomimetic peptide and agonist that specifically targets the juxtamembrane amino acid sequence of the ectodomain of CD31. By restoring the CD31 inhibitory pathway, P8RI exhibits immunosuppressive properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | Inquiry | Inquiry | |
100 mg | Inquiry | Inquiry |
Description | P8RI (D-P8RI) is a CD31 biomimetic peptide and agonist that specifically targets the juxtamembrane amino acid sequence of the ectodomain of CD31. By restoring the CD31 inhibitory pathway, P8RI exhibits immunosuppressive properties. |
In vitro | P8RI (D-P8RI) was designed as a retro-inverso peptide with all-D-amino acids allowing to maintain bioactivity and to confer resistance towards plasma proteases[1]. |
In vivo | P8RI, administered at a dosage of 2.5 mg/kg through subcutaneous injections daily from days 7 to 28 following acute aortic dissection and intramural hematoma (ADIM) occurrence, significantly mitigates aneurysmal transformation. This effect is achieved by hastening the resolution of intramural hematomas, fostering collagen production in dissected aortas, and enhancing M2 macrophage enrichment at the injury site in vivo. The efficacy of this treatment was evaluated using an Apo E -/- male mouse model, 28-week-old, with implanted Ang II-releasing pumps—a model designed to simulate experimental acute aortic dissection and intramural hematoma (ADIM). This regimen resulted in a marked reduction of aneurysmal transformation. |
Synonyms | D-P8RI |
Molecular Weight | 1016.259 |
Formula | C51H77N13O9 |
CAS No. | 2147724-76-1 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
P8RI 2147724-76-1 D-P8RI P-8RI inhibitor inhibit